Outcomes of Medicare Beneficiaries With Heart Failure and Atrial Fibrillation

被引:59
作者
Khazanie, Prateeti [1 ,2 ]
Liang, Li [1 ]
Qualls, Laura G. [1 ]
Curtis, Lesley H. [1 ,2 ]
Fonarow, Gregg C. [3 ]
Hammill, Bradley G. [1 ,4 ]
Hammill, Stephen C.
Heidenreich, Paul A. [5 ]
Masoudi, Frederick A. [6 ]
Hernandez, Adrian F. [1 ,2 ]
Piccini, Jonathan P. [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[3] Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA
[4] Mayo Clin, Rochester, MN USA
[5] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
[6] Univ Colorado, Aurora, CO USA
基金
美国医疗保健研究与质量局;
关键词
atrial fibrillation; heart failure; Medicare; mortality outcome; assessment (health care); patient readmission; VENTRICULAR SYSTOLIC DYSFUNCTION; PROFILING HOSPITAL PERFORMANCE; OPTIMIZE-HF; MORTALITY; RISK; REGISTRY; STROKE; READMISSION; RIVAROXABAN; PROGRESSION;
D O I
10.1016/j.jchf.2013.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study sought to examine the long-term outcomes of patients hospitalized with heart failure and atrial fibrillation. Background Atrial fibrillation is common among patients hospitalized with heart failure. Associations of pre-existing and new-onset atrial fibrillation with long-term outcomes are unclear. Methods We analyzed 27,829 heart failure admissions between 2006 and 2008 at 281 hospitals in the American Heart Association's Get With The Guidelines-Heart Failure program linked with Medicare claims. Patients were classified as having pre-existing, new-onset, or no atrial fibrillation. Cox proportional hazards models were used to identify factors that were independently associated with all-cause mortality, all-cause readmission, and readmission for heart failure, stroke, and other cardiovascular disease at 1 and 3 years. Results After multivariable adjustment, pre-existing atrial fibrillation was associated with greater 3-year risks of all-cause mortality (hazard ratio [HR]: 1.14 [99% confidence interval (CI): 1.08 to 1.20]), all-cause readmission (HR: 1.09 [99% CI: 1.05 to 1.14]), heart failure readmission (HR: 1.15 [99% CI: 1.08 to 1.21]), and stroke readmission (HR: 1.20 [99% CI: 1.01 to 1.41]), compared with no atrial fibrillation. There was also a greater hazard of mortality at 1 year among patients with new-onset atrial fibrillation (HR: 1.12 [99% CI: 1.01 to 1.24]). Compared with no atrial fibrillation, newonset atrial fibrillation was not associated with a greater risk of the readmission outcomes. Stroke readmission rates at 1 year were just as high for patients with preserved ejection fraction as for patients with reduced ejection fraction. Conclusions Both pre-existing and new-onset atrial fibrillation were associated with greater long-term mortality among older patients with heart failure. Pre-existing atrial fibrillation was associated with greater risk of readmission. (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [41] Anticoagulation in atrial fibrillation and chronic heart failure: the risk and drug of choice
    Boos, Christopher J.
    Brown, Louise
    CURRENT OPINION IN CARDIOLOGY, 2016, 31 (02) : 229 - 234
  • [42] Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant
    Brown, Louise A. E.
    Boos, Christopher J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 : 863 - 868
  • [43] The impact of catheter ablation for atrial fibrillation in heart failure
    Moschonas, Konstantinos
    Nabeebaccus, Adam
    Okonko, Darlington O.
    McDonagh, Theresa A.
    Murgatroyd, Francis D.
    Dhillon, Para
    Scott, Paul A.
    JOURNAL OF ARRHYTHMIA, 2019, 35 (01) : 33 - 42
  • [44] Atrial fibrillation and congestive heart failure
    Roy, Denis
    Talajic, Mario
    Dubuc, Marc
    Thibault, Bernard
    Guerra, Peter
    Macle, Laurent
    Khairy, Paul
    CURRENT OPINION IN CARDIOLOGY, 2009, 24 (01) : 29 - 34
  • [45] The importance of interactions between atrial fibrillation and heart failure
    Khan, Muhammad A.
    Satchithananda, Duwarakan K.
    Mamas, Mamas A.
    CLINICAL MEDICINE, 2016, 16 (03) : 272 - 276
  • [46] Atrial fibrillation ablation in heart failure
    Richter, Sergio
    Di Biase, Luigi
    Hindricks, Gerhard
    EUROPEAN HEART JOURNAL, 2019, 40 (08) : 663 - +
  • [47] The mutual relationship between heart failure and atrial fibrillation
    Sarullo, Filippo M.
    Schembri, Giuseppe
    Nugara, Cinzia
    Sarullo, Silvia
    Vitale, Giuseppe
    Corrao, Salvatore
    MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (04) : 299 - 303
  • [48] Managements and outcomes of hospitalized heart failure patients with paroxysmal vs nonparoxysmal atrial fibrillation in Taiwan
    Chang, Hung-Yu
    Feng, An-Ning
    Fong, Man-Cai
    Chong, Eric
    Yin, Wei-Hsian
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (05) : 356 - 362
  • [49] Atrial Fibrillation in Patients Hospitalized With Heart Failure: Patient Characteristics and Outcomes From the HEARTS Registry
    Ajlan, M.
    Almazroa, L.
    AlHabib, Khalid F.
    Elasfar, Abdelfatah A.
    Alfaleh, Hussam
    Albackr, Hanan
    Kashour, Tarek
    Hersi, Ahmad
    Hussein, Gamal A.
    Mimish, Layth
    Almasood, Ali
    AlHabeeb, Waleed
    AlGhamdi, Saleh
    Alsharari, Mubrouk
    Chakra, Esmail
    Malik, Asif
    Soomro, Raza
    Ghabashi, Abdullah
    Al-Murayeh, Mushabab
    Abuosa, Ahmed
    ANGIOLOGY, 2018, 69 (02) : 151 - 157
  • [50] Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF
    Dubner, Sergio J.
    Teutsch, Christine
    Huisman, Menno V.
    Diener, Hans-Christoph
    Halperin, Jonathan
    Rothman, Kenneth J.
    Ma, Chang-Sheng
    Chuquiure-Valenzuela, Eduardo
    Bergler-Klein, Jutta
    Zint, Kristina
    Riou Franca, Lionel
    Lu, Shihai
    Paquette, Miney
    Lip, Gregory Y. H.
    ESC HEART FAILURE, 2020, 7 (05): : 2679 - 2689